Nufarm Limited · ASX:NUF

Nufarm — Merger or Acquisition (November 2017)

8 slides from Nufarm's merger presentation, Nov 8, 2017

  1. Slide 1: Acquisition of European herbicide product portfolio from FMC

    For personal use only Acquisition of European herbicide product portfolio from FMC 8 November 2017 NOT FOR DISTRIBUTION IN THE UNITED STATES

  2. Slide 2: Important notice and disclaimer

    Important notice and disclaimer This presentation has been prepared by Nufarm Limited ACN 091 323 312 (“Nufarm" or the "Company"). This presentation has been prepared in relation to the acquisition of certain cereal broadleaf herbicide assets within the European Economic Area from FMC Corporation (“

  3. Slide 3: Important notice and disclaimer

    Important notice and disclaimer The presentation includes certain "forward-looking statements" such as indications of, and guidance on, future events, future earnings and the future financial performance and financial position of Nufarm. Forward looking statements can generally be identified by the

  4. Slide 4: Overview of the transaction

    Overview of the transaction Agreement to acquire certain cereal broadleaf herbicide assets in the European Economic Area ("EEA") from FMC Corporation ("FMC") for US$851 million plus approximately US$5 million for inventory2 For personal use only  As previously announced on 24 October, Nufarm has be

  5. Slide 5: Compelling strategic rationale

    Compelling strategic rationale The acquired portfolio is highly complementary to Nufarm's existing European business, including the recently announced acquisition of the Century Portfolio For personal use only 3 Closely aligned to Nufarm's strategy – Strengthens Nufarm’s presence in cereals and past

  6. Slide 6: Overview of the portfolio

    Overview of the portfolio The acquired portfolio consists of branded products for use as post-emergence cereal broadleaf herbicides For personal use only Overview of portfolio Key brands  Acquired portfolio consists of the business assets, related rights and registrations for four active ingredient

  7. Slide 7: Financial overview and outlook

    Financial overview and outlook  The acquired portfolio is expected to contribute net sales of approximately A$30 million in the first full year under Nufarm For personal use only ownership (FY19)1  Attractive near term growth profile driven by new product launches along with cross-selling opportun

  8. Slide 8: For personal use only

    For personal use only NOT FOR DISTRIBUTION IN THE UNITED STATES

Nufarm — Merger or Acquisition (November 2017) on 6ix